These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

220 related articles for article (PubMed ID: 7533701)

  • 1. Hypertension treatment and prevention of new atherosclerotic plaque formation.
    Rafflenbeul W
    Drugs; 1994; 48 Suppl 1():11-5. PubMed ID: 7533701
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Calcium antagonists and atherosclerosis protection in hypertension.
    Hernández RH; Armas-Hernández MJ; Velasco M; Israili ZH; Armas-Padilla MC
    Am J Ther; 2003; 10(6):409-14. PubMed ID: 14624278
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Accelerated atherosclerosis.
    Samra SS; Walwaikar PP; Morye VK; Gawde AG
    J Indian Med Assoc; 2002 Aug; 100(8):516, 518-21. PubMed ID: 12675186
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Endothelium, atherosclerosis and calcium channel blockers.
    Biswas TK
    J Indian Med Assoc; 2003 Jul; 101(7):428-31. PubMed ID: 14748381
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cellular proliferation in atherosclerosis and hypertension.
    Schwartz SM; Ross R
    Prog Cardiovasc Dis; 1984; 26(5):355-72. PubMed ID: 6371894
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Modulation of endothelial function: strategy for long-term cardiovascular protection.
    Haller H
    J Hypertens Suppl; 1996 Nov; 14(4):S27-32. PubMed ID: 8986940
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Calcium channel blockers, endothelial dysfunction, and combination therapy.
    Schulman IH; Zachariah M; Raij L
    Aging Clin Exp Res; 2005 Aug; 17(4 Suppl):40-5. PubMed ID: 16640172
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Calcium antagonists and ACE inhibitors. Effect on endothelium and vascular smooth muscle.
    Lüscher TF; Yang Z
    Drugs; 1993; 46 Suppl 2():121-32. PubMed ID: 7512465
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Recent advances in molecular pathology. The effects of hypertension on the arterial wall.
    Chobanian AV; Prescott MF; Haudenschild CC
    Exp Mol Pathol; 1984 Aug; 41(1):153-69. PubMed ID: 6381089
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Anti-atherosclerotic action of hypotensive drugs].
    Gmiński J; Stajszczyk M
    Wiad Lek; 1996; 49(7-12):182-98. PubMed ID: 9245114
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Experimental vasoprotection by calcium antagonists against calcium-mediated arteriosclerotic alterations.
    Fleckenstein-Grün G; Thimm F; Czirfuzs A; Matyas S; Frey M
    J Cardiovasc Pharmacol; 1994; 24 Suppl 2():S75-84. PubMed ID: 7898099
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Hypertension and vascular diseases: molecular and cellular mechanisms].
    Lüscher TF
    Schweiz Med Wochenschr; 1995 Feb; 125(7):270-82. PubMed ID: 7878405
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The endothelium in coronary artery disease.
    Ruschitzka FT; Noll G; Lüscher TF
    Cardiology; 1997; 88 Suppl 3():3-19. PubMed ID: 9397288
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Endothelial dysfunction and hypertension.
    Ferro CJ; Webb DJ
    Drugs; 1997; 53 Suppl 1():30-41. PubMed ID: 9034753
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Role of hypertension in atherosclerosis and cardiovascular disease.
    Hollander W
    Am J Cardiol; 1976 Nov; 38(6):786-800. PubMed ID: 136891
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Anti-atherosclerotic properties of nifedipine. Benefit of early intervention to prevent cardiovascular complications.
    Rafflenbeul W
    Cardiology; 1997; 88 Suppl 3():52-5. PubMed ID: 9397295
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The role of platelets in the development and complications of atherosclerosis.
    Packham MA; Mustard JF
    Semin Hematol; 1986 Jan; 23(1):8-26. PubMed ID: 3511536
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cellular processes in atherogenesis: potential targets of Ca2+ channel blockers.
    Schmitz G; Hankowitz J; Kovacs EM
    Atherosclerosis; 1991 Jun; 88(2-3):109-32. PubMed ID: 1654052
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The antiatherosclerotic effect of the calcium antagonists and their implications in hypertension.
    Nayler WG; Panagiotopoulos S
    Am Heart J; 1993 Feb; 125(2 Pt 2):626-9. PubMed ID: 8430608
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The role of calcium antagonists in the treatment of atherosclerosis and hypertension.
    Ouchi Y; Orimo H
    J Cardiovasc Pharmacol; 1990; 16 Suppl 2():S1-4. PubMed ID: 1369701
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.